Connection

Robert Haile to Mutation

Back to Details
This is a "connection" page, showing publications Robert Haile has written about Mutation.
Robert Haile
Connection Strength
2.042
Mutation
  1. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1863-70.
    View in: PubMed
    Score: 0.184
  2. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 01; 22(1):15-25.
    View in: PubMed
    Score: 0.112
  3. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Fam Cancer. 2015 Dec; 14(4):575-83.
    View in: PubMed
    Score: 0.087
  4. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53.
    View in: PubMed
    Score: 0.085
  5. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome. JAMA. 2015 Jul 07; 314(1):61-71.
    View in: PubMed
    Score: 0.084
  6. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014 May; 146(5):1208-11.e1-5.
    View in: PubMed
    Score: 0.076
  7. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat. 2013 Jan; 34(1):200-9.
    View in: PubMed
    Score: 0.070
  8. Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol. 2012 May; 107(5):782-9.
    View in: PubMed
    Score: 0.067
  9. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):681-4.
    View in: PubMed
    Score: 0.067
  10. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
    View in: PubMed
    Score: 0.067
  11. Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women. Cancer Prev Res (Phila). 2011 Dec; 4(12):2035-43.
    View in: PubMed
    Score: 0.065
  12. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
    View in: PubMed
    Score: 0.063
  13. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Res Treat. 2011 Jun; 127(3):819-29.
    View in: PubMed
    Score: 0.062
  14. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol. 2011 Jun; 9(6):497-502.
    View in: PubMed
    Score: 0.061
  15. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010 Jul 21; 102(14):1012-22.
    View in: PubMed
    Score: 0.060
  16. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
    View in: PubMed
    Score: 0.059
  17. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010 Mar; 31(3):E1200-40.
    View in: PubMed
    Score: 0.058
  18. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
    View in: PubMed
    Score: 0.058
  19. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46.
    View in: PubMed
    Score: 0.058
  20. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15; 68(16):6486-91.
    View in: PubMed
    Score: 0.052
  21. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006 Jul; 38(7):787-93.
    View in: PubMed
    Score: 0.045
  22. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.
    View in: PubMed
    Score: 0.042
  23. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA. 2005 Feb 16; 293(7):799-809.
    View in: PubMed
    Score: 0.041
  24. Breast cancer risks for BRCA1/2 carriers. Science. 2004 Dec 24; 306(5705):2187-91; author reply 2187-91.
    View in: PubMed
    Score: 0.041
  25. Cancer Risks for PMS2-Associated Lynch Syndrome. J Clin Oncol. 2018 10 10; 36(29):2961-2968.
    View in: PubMed
    Score: 0.026
  26. Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260.
    View in: PubMed
    Score: 0.026
  27. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017 Jul 19; 19(1):83.
    View in: PubMed
    Score: 0.024
  28. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):404-412.
    View in: PubMed
    Score: 0.023
  29. Development of prognostic signatures for intermediate-risk papillary thyroid cancer. BMC Cancer. 2016 09 15; 16(1):736.
    View in: PubMed
    Score: 0.023
  30. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):68-75.
    View in: PubMed
    Score: 0.022
  31. Lynch syndrome and cervical cancer. Int J Cancer. 2015 Dec 01; 137(11):2757-61.
    View in: PubMed
    Score: 0.021
  32. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1547-56.
    View in: PubMed
    Score: 0.018
  33. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women. Gastroenterology. 2013 Aug; 145(2):348-56.e1-2.
    View in: PubMed
    Score: 0.018
  34. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36.
    View in: PubMed
    Score: 0.018
  35. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013 Feb 01; 31(4):433-9.
    View in: PubMed
    Score: 0.018
  36. Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med. 2012 Jul; 14(7):670-80.
    View in: PubMed
    Score: 0.017
  37. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer. 2012; 64(7):899-910.
    View in: PubMed
    Score: 0.017
  38. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut. 2012 Sep; 61(9):1299-305.
    View in: PubMed
    Score: 0.016
  39. Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat. 2012 Jan; 33(1):158-64.
    View in: PubMed
    Score: 0.016
  40. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.
    View in: PubMed
    Score: 0.015
  41. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.015
  42. Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat. 2010 Feb; 120(1):175-83.
    View in: PubMed
    Score: 0.014
  43. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008 Jan 09; 299(2):194-201.
    View in: PubMed
    Score: 0.013
  44. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 2007 Dec 01; 67(23):11128-32.
    View in: PubMed
    Score: 0.012
  45. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer. Hum Mutat. 2003 May; 21(5):542-50.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.